|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Vital Therapies, Inc.
| | | Phone: | (858) 673-6840 | Fax: | (858) 673-6843 | Year Established: | 2003 | Ticker: | VTL | Exchange: | NASDAQ | Main Contact: | Duane Nash, M.D., J.D., M.B.A., President | | Other Contacts: | Albert Kildani, VP, Investor Relations & Business Development Aron P. Stern, M.B.A., Chief Administration Officer Richard Murawski, VP, of Manufacturing Andrea Loewen, VP, Regulatory Affairs and Quality John Dunn, General Counsel Andrew Henry, VP, Clinical Operations Michael V. Swanson, M.B.A., CFO Robert Ashley, MA, CTO Russell J. Cox, CEO Faheem Hasnain, Chairman
| | Company Description | Vital Therapies is a biotherapeutic company developing a cell-based system for the treatment of acute forms of liver failure. The company’s lead product candidate, the ELAD® System, is a human cell-based, bio-artificial liver support system currently in Phase III clinical trials. | |
|
|
|
|
|